Well im certainly no expert but the current GLOBAL market forcast for cell and gene therapy by 2032 is expected to be $44B.......ur talking msb alone to be a $50B company...so unless ur talking the next 10-15 (minimum)? Years then i personally think its unrealistic.....look,like i said iv got alot invested here and have been in and havent sold a share in 4+years and i hope im completely wrong on this but i just cant see $50aud per share at least in the next 10-15 years
Upcoming Newsflow & Re-rate Estimations, page-36
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.015(1.39%) |
Mkt cap ! $1.210B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.08 | $1.05 | $2.331M | 2.193M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 19381 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 68221 | 14 |
View Market Depth
| Last trade - 12.40pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.07 |
Change
-0.015 ( 1.45 %) |
||||
| Open | High | Low | Volume | ||
| $1.07 | $1.08 | $1.05 | 367221 | ||
| Last updated 12.59pm 17/06/2024 ? | |||||
| MSB (ASX) Chart |
